Skip to main content
. 2010 Oct 15;5(10):e13407. doi: 10.1371/journal.pone.0013407

Figure 3. Threshold analysis of the cost-effectiveness of IPTp-SPa.

Figure 3

a Intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine b 129 US$/DALY averted. c 36 US$/DALY averted. Within the simulation ranges of each variable: * a threshold of 92.92 US$ was reached only. † a threshold of 96.79 US$ was reached only. ‡ a threshold of 85.99 US$ was reached only. ξ a threshold of 97.25 US$ was reached only.